Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.89 USD | -1.59% | -0.10% | +10.38% |
May. 21 | GCM Grosvenor Invests in Healthcare Investment Firm | MT |
May. 20 | Piper Sandler Adjusts GCM Grosvenor Price Target to $10.50 From $10, Maintains Neutral Rating | MT |
Evolution of the average Target Price on GCM Grosvenor Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering GCM Grosvenor Inc.
Piper Sandler | |
Oppenheimer | |
UBS | |
TD Cowen | |
Credit Suisse | |
JPMorgan Chase | |
BofA Securities | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- GCMG Stock
- Consensus GCM Grosvenor Inc.